Supplementary MaterialsSupplementary File
Supplementary MaterialsSupplementary File. TNBC. bar graph). (bar graph). ( 0.05, ** 0.005 by 2-tailed test. VEGFCNRP signaling can function in TNBC and other cancer cells independently of the VEGFRs (8C12). This observation is significant because bevacizumab, the most common anti-VEGF therapy, blocks VEGF binding to VEGFRs, but it does not disrupt the VEGFCNRP association or … [Read more…]